Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Iptacopan in Patients With ANCA Associated Vasculitis [Phase 2]
Iptacopan is being studied in a Phase 2 clinical trial for ANCA-associated vasculitis. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: BDB-001 Phase III Trial in ANCA-Associated Vasculitis [Phase 3]
Phase III clinical trial of BDB-001 for ANCA-associated vasculitis is currently recruiting, sponsored by Staidson (Beijing) Biopharmaceutica…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases [EARLY_Phase 1]
An early Phase 1 clinical study evaluating the safety and efficacy of GT719 universal cell injection for immune-mediated kidney diseases is …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: MTS109 in Patients With Refractory Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 clinical trial evaluating MTS109 in adults with refractory autoimmune diseases is currently recruiting. The study includes systemi…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders [Phase 1, Phase 2]
Descartes-08 by Cartesian Therapeutics is in Phase 1/2 and currently recruiting for pediatric/young adult trials in childhood-onset systemic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease [EARLY_Phase 1]
An early-phase trial of allogeneic CD19/BCMA CAR-T therapy for B-cell–related autoimmune diseases is recruiting at The Children's Hospital o…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update on an allogeneic CD19/BCMA-targeted CAR-γδT cell therapy assessing safety and preliminary pharmacodynamics in …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease [Phase 3]
Phase 3 clinical trial assessing whether maintaining or stopping immunosuppressive therapy is appropriate for patients with ANCA-associated …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NIAMS sponsors a clinical trial to study the natural history, pathogenesis, and outcomes of idiopathic systemic vasculitis, with recruiting …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease [Phase 1]
Phase 1 trial update for Prulacabtagene Leucel (Prula-cel) in autoimmune diseases, with enrollment by invitation ongoing across indications …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease [Phase 1]
Phase 1 study update for FT819 in B-cell–mediated autoimmune diseases; recruitment is ongoing for ANCA-associated vasculitis, idiopathic inf…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. [Phase 3]
A Phase 3 pediatric trial evaluating avacopan in combination with a rituximab- or cyclophosphamide-containing regimen for ANCA-associated va…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a targeted CD19 or CD19-BCMA CAR-T therapy for autoimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 4]
A Phase 4 clinical trial comparing clinico-biological monitoring to pre-emptive rituximab for ANCA reappearance in granulomatosis with polya…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]
Phase 1 trial update on YTS109 cell therapy for relapsed/refractory autoimmune diseases, currently recruiting across multiple indications.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 in pediatric relapsed/refractory autoimmune diseases, including SLE and diffuse systemic sclerosi…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 [Phase 1]
Phase 1 study update for KYV-101 (CARTIMMUNE) evaluating autoimmune diseases including idiopathic inflammatory myopathies, diffuse cutaneous…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial of TI-0032-III Injection for relapsed and refractory autoimmune diseases is currently recruiting, encompassing seve…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis
A recruiting clinical trial at the University of Edinburgh is evaluating how PET imaging correlates disease activity and cardiovascular risk…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: An Exploratory Study of MT-2990 in Patients With AAV [Phase 1]
A completed Phase 1 exploratory study of MT-2990 in patients with ANCA-associated vasculitis (AAV).
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease [NA]
A completed clinical trial comparing removal kinetics of ANCA and anti-GBM autoantibodies using plasma exchange versus immunoadsorption in p…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 targeted CD19 CAR-T therapy trial for autoimmune diseases has been suspended.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for a CAR T-cell therapy targeting CD19 and BCMA in autoimmune conditions, with recruiting status and potentia…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.